NCT00389051
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Kanagawa, Japan
- Kyoto, Japan
- Nagoya, Japan
- Tokyo, Japan
Clinical trial condition
Non-Hodgkin's Lymphoma
Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.
250 public trials
21 recruiting studies
Non-Hodgkin's Lymphoma trial results
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Completed
Zevalin-beam for Aggressive Lymphoma
NCT00491491
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- Cedars Sinai Medical Center Los Angeles, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT00042666
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Royal Oak, Michigan, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rochester, Minnesota, United States
NCT01854567
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +17 more
- Locations
-
- University of Miami Health System Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
NCT01109069
- Conditions
- B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
- Locations
-
- Stanford University Stanford, California, United States
- Stanford, California, United States
- University of Chicago Chicago, Illinois, United States
- Boston, Massachusetts, United States
Completed
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
NCT03027284
- Conditions
- Adenocarcinoma, Advanced Cancer, Biliary Tract Carcinoma, +27 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan
Completed
Meloxicam vs Placebo for Mobilization
NCT02003625
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
- Locations
-
- Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Iowa Iowa City, Iowa, United States
Completed
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
NCT01491841
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States